Reach Us +44-7460312890
Metabolic Syndrome, Wall Motion Score and Infarct Size after AMI | OMICS International
ISSN: 2329-9517
Journal of Cardiovascular Diseases & Diagnosis
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Metabolic Syndrome, Wall Motion Score and Infarct Size after AMI

Leonardo S. Roever-Borges* and Resende ES
Department of Clinical Research, Federal University of Uberlândia, Brazil
Corresponding Author : Leonardo S. Roever-Borges
Av. Para, 1720 - Bairro Umuarama
Uberlândia - MG - CEP 38400-902, Brazil
Tel: +553488039878
E-mail: [email protected]
Received: August 03, 2015; Accepted: August 07, 2015; Published: August 10, 2015
Citation: Roever L, Resende ES (2015) Metabolic Syndrome, Wall Motion Score and Infarct Size after AMI. J Cardiovasc Dis Diagn 3:e108.doi:10.4172/2329-9517.1000e108
Copyright: © 2015 Roever L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google

Visit for more related articles at Journal of Cardiovascular Diseases & Diagnosis


The infarct size is an important marker for early and late mortality after acute myocardial infarction [1,2]. The metabolic syndrome (MetS) is interrelated atherosclerotic risk factors including insulin resistance, hypertension, a low level of high-density lipoprotein (HDL) cholesterol, a high triglyceride level, a high plasma glucose concentration, central obesity, and the increased number of components of the metabolic syndrome is associated with a higher mean carotid intima media thickness, lower ankle brachial pressure index in patients with coronary heart disease, peripheral arterial disease, or abdominal aortic aneurysm [3-5].

Hajsadeghi et al. reported a study with 100 patients with MetS (group I) and 100 control (group II) who experienced acute myocardial infarction. In this study the left ventricle (LV) was divided into six basal segments (anterior, anterolateral, inferolateral, inferior, inferoseptal, and anteroseptal), six middle segments (same subgroups), and four apically located segments (anterior, septal, inferior, and posterior). By visual analysis of systolic wall thickening, segments were assigned a wall motion score (WMS) as follows:

• Normal or hyperkinetic (normal endocardial excursion and systolic wall thickening);
• Hypokinetic (reduced excursion and wall thickening);
• Akinetic (absent excursion and wall thickening); and
• Dyskinetic (paradoxical systolic outward wall motion).
WMS index (WMSI) was calculated by dividing the sum of all WMS by the total number of segments analyzed [1].

The authors found that the peak CK-MB and cTnI in 72 hours it was significantly higher in patients with MetS compared with control subjects (P <0.001). After 72 hours patients with metabolic syndrome have markedly superior wall motion abnormality assessed by echocardiography derived wall motion score index (WMSI) (P <0.001). Also found statistically significant relationships between WMSI and peak CK-MB and also cTnI at 72 hours (P <0.001) (1).

Logstrup et al. studied the effects of known DM, newly diagnosed DM, and impaired glucose tolerance (IGT) on echocardiography-derived coronary flow reserve (CFR) in a group of patients with recent AMI. The authors an association between a decreased CFR and the diagnosed DM but not the IGT [6].

The patients with MetS have significantly higher infarct size compared to those without metabolic syndrome.

  1. Hajsadegh S, Chitsazan M, Chitsazan M,  Haghjoo M,  Babaali N, NorouzzadehZ,et. al. (2015) Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction. Res Cardiovasc Med 4: e25018.

  2. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, et al. (1995) Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92:334–341.

  3. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159:1104–1109.

  4. Grundy SM (1999) Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol83:25f–9f.

  5. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, et al. (2004) The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J25:342–348.

  6. Logstrup BB, Hofsten DE, Christophersen TB, Moller JE, et al. (2009) Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction.JACC Cardiovasc Imaging 2:1159–1166.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12277
  • [From(publication date):
    September-2015 - Jan 21, 2020]
  • Breakdown by view type
  • HTML page views : 8451
  • PDF downloads : 3826